Xenetic Biosciences Inc. Revenue 2012–2025
Xenetic Biosciences Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Xenetic Biosciences Inc. revenue for the quarter ending March 31, 2026 was 806923, a 36.01% increase year-over-year.
- Xenetic Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 3.0 M, a 22.51% increase year-over-year.
- Xenetic Biosciences Inc. annual revenue for 2025 was 3.0 M, a 19.04% increase from 2024.
- Xenetic Biosciences Inc. annual revenue for 2024 was 2.5 M, a 1.56% decrease from 2023.
- Xenetic Biosciences Inc. annual revenue for 2023 was 2.5 M, a 48.80% increase from 2022.
- Xenetic Biosciences Inc. annual revenue for 2022 was 1.7 M.
Xenetic Biosciences Inc. (XBIO) — Frequently Asked Questions
Xenetic Biosciences Inc. (XBIO) is a publicly traded US company. It has a market capitalization of $5M. In fiscal 2025 it reported revenue of $3M and net income of -$3M. Explore XBIO's stock price, financial statements, earnings history, margins and key ratios below.
What is Xenetic Biosciences Inc.'s market cap?
Xenetic Biosciences Inc. (XBIO) has a market capitalization of $5M.
What is the XBIO stock price?
XBIO trades at $3.00 (-2.69% on the day).
How much revenue does Xenetic Biosciences Inc. make?
Xenetic Biosciences Inc. reported revenue of $3M in fiscal 2025.
Is XBIO profitable?
In fiscal 2025, Xenetic Biosciences Inc. reported net income of -$3M.